Not only is SIGNiX's e-signature solution able to speed up the completion of trial documentation up to 94% by enabling digital signing, our solution meets 21 CFR 11. PharmaDoX brings easy, independent, digital certificate signing to life sciences without the burden of on-site servers and hardware tokens. Click here to read a case study of why Sarah Cannon Research Institute chose SIGNiX and how it has transformed their clinical trials.
Don’t miss out on seeing SIGNiX live at Disruptive Innovations; visit us at Booth #25. Also, hear John Harris, SVP of Product Management, take the spotlight at 4:00 p.m. on September 10 to discuss saving time and money by going paperless.